Talling, Sitti Nurhata .
HRN: 23-33-41 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/03/2024
AMPICILLIN 1GM (VIAL)
03/03/2024
03/03/2024
IV
2g
Q6hrs
PROM X 3 HOURS, GROSSLY LEAKING BOW
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes